Mwandishi:
ULY CLINIC
Mhariri:
ULY CLINIC
Imeboreshwa:
19 Februari 2026, 01:16:27
Opioid poisoning
Opioid poisoning (Opiate overdose) is a life-threatening toxicological emergency caused by excessive stimulation of opioid receptors — primarily µ-opioid receptors in the brainstem respiratory centers. The most dangerous effect is respiratory depression leading to hypoxia, coma and death.
Poisoning may occur at any age:
Neonates — maternal opioid exposure
Children — accidental ingestion
Adults — therapeutic error, substance misuse
Palliative care — dosing accumulation
Common causative agents include:
Codeine
Dihydrocodeine
Morphine
Heroin
Methadone
Tramadol
Fentanyl
Loperamide (high dose misuse)
Opium preparations
Diamorphine
Polysubstance ingestion (opioids + alcohol/benzodiazepines) greatly increases mortality risk.
2. Pathophysiology
Opioids bind to central nervous system receptors:
Receptor | Effect |
µ (mu) | Respiratory depression, euphoria, miosis |
κ (kappa) | Sedation |
δ (delta) | Analgesia |
Major lethal mechanism:suppression of medullary respiratory center → CO₂ retention → hypoxia → cardiac arrest
Additional effects:
Reduced gastrointestinal motility
Reduced sympathetic tone
Increased vagal tone
Pulmonary edema
CNS depression
3. Risk Factors
Substance use disorder
Previous overdose
Recent detoxification (loss of tolerance)
Concurrent alcohol or sedatives
Chronic lung disease
Chronic kidney disease (drug accumulation)
Elderly age
Neonates born to opioid-using mothers
High potency synthetic opioids (fentanyl analogues)
Social disadvantage and homelessness
4. Clinical Features
Classic Opioid Toxidrome (Triad)
Depressed consciousness
Pinpoint pupils (miosis)
Respiratory depression
Acute Toxicity
Neurological
Drowsiness
Confusion
Slurred speech
Coma
Respiratory
Bradypnea (<12/min)
Shallow breathing
Cyanosis
Apnoea
Gastrointestinal
Nausea
Vomiting
Cardiovascular
Hypotension
Bradycardia (occasionally tachycardia)
Shock in severe cases
Pupils
Pinpoint pupils (may dilate in severe hypoxia)
Chronic Toxicity / Dependence
Constipation
Anorexia
Nausea
Endocrine suppression
Tolerance
Withdrawal on cessation
Neonatal Opioid Toxicity
Poor feeding
Respiratory depression
Hypotonia
Apnoea
5. Diagnostic Criteria
Diagnosis is primarily clinical.
Suspect opioid poisoning in any patient with:
Altered consciousness
Hypoventilation
Pinpoint pupils
Response to naloxone confirms diagnosis.
6. Investigations
Bedside
Pulse oximetry
Capillary glucose (exclude hypoglycemia)
Arterial blood gas (respiratory acidosis)
Laboratory
Serum electrolytes
Renal function tests
Toxicology screen
Serum drug levels (if available)
Imaging
Chest X-ray — aspiration pneumonia / pulmonary edema
CT brain if diagnosis uncertain
7. Management
Treat immediately — do NOT wait for lab confirmation
7.1 Initial Resuscitation (ABCDE)
Airway
Position airway
Remove secretions
Intubate if airway unprotected
Breathing
Oxygen 10–15 L/min
Assist ventilation with bag-valve mask
Circulation
IV access
Monitor ECG
Treat hypotension with fluids
7.2 Antidote Therapy — Naloxone
Naloxone is a competitive opioid antagonist with rapid onset (1–2 minutes IV).
Hypoventilating patient (spontaneous breathing)
Adults & Children >20 kg
Initial:0.5 mg IV
Titrate every 2–3 minutes until RR ≥ 12/min
Children <20 kg
0.01 mg/kg IV(Max 2 mg/dose)
Apnoea
Neonates (maternal opioid exposure)
0.01 mg/kg IV/IM(Max 0.4 mg/dose)
Children <20 kg
0.1 mg/kg IV(Max 2 mg/dose)
Repeat or infusion if needed
Adults / >20 kg
2 mg IVRepeat every 3 minutes up to 10 mg total
If no response → consider other diagnosis
Continuous Infusion
Required for long-acting opioids (e.g. methadone)
Dose:2/3 effective reversal dose per hour
Important Warning
Rapid reversal may cause:
Severe withdrawal
Pulmonary edema
Cardiac arrhythmia
Use lowest effective dose especially in neonates.
7.3 Supportive Care
Cardiac monitoring
Observe minimum 6–24 hours (longer for methadone)
Prevent aspiration
Treat pulmonary edema
Manage withdrawal if occurs
8. Complications
Hypoxic brain injury
Aspiration pneumonia
Acute respiratory distress syndrome
Rhabdomyolysis
Death
9. Prevention
Do’s
Store medicines safely
Child-resistant containers
Read labels carefully
Don’ts
Transfer medications
Leave containers open
Call medicine sweets
Take drugs in front of children
Public Health Measures
Opioid prescribing control
Addiction treatment programs
Take-home naloxone programs
Patient education
10. Prognosis
Condition | Outcome |
Early naloxone | Full recovery |
Delayed treatment | Brain injury |
Long-acting opioids | Re-sedation risk |
Untreated apnoea | Death |
References
Tanzania Ministry of Health. Standard Treatment Guidelines and Essential Medicines List for Tanzania Mainland. 7th ed. Dodoma: Ministry of Health; 2023.
World Health Organization. Community management of opioid overdose. Geneva: WHO; 2014.
Nelson LS, Howland MA, Lewin NA, Smith SW, Goldfrank LR, Hoffman RS. Goldfrank’s Toxicologic Emergencies. 11th ed. New York: McGraw-Hill; 2019.
Tintinalli JE, Ma O, Yealy DM, et al. Tintinalli’s Emergency Medicine: A Comprehensive Study Guide. 9th ed. New York: McGraw-Hill; 2020.
Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367(2):146-155.
American College of Medical Toxicology. ACMT position statement: naloxone dosing in opioid overdose. J Med Toxicol. 2015;11(3):302-305.
StatPearls Publishing. Opioid Toxicity. Treasure Island (FL): StatPearls; 2024.
